Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Arthritis and Rheumatism|July 1, 1996
Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year followupR J McKendry, L Huebsch, B LeclairBone Marrow Transplantation|March 12, 2014
A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access ProgramD Sheppard, C Bredeson, L Huebsch, et al.Bone Marrow Transplantation|December 24, 1997
Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC)C Bredeson, J Malcolm, M Davis, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2000
Autologous blood and marrow transplantation in patients 60 years and olderC S Leger, C Bredeson, B Kearns, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 15, 1987
Registry of unrelated bone marrow donorsG Rock, F Decary, N McCombie, et al.Bone Marrow Transplantation|December 1, 2009
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomesS McDiarmid, B Hutton, H Atkins, et al.Canadian Respiratory Journal|August 26, 1998
Dead space ventilation parallels changes in scintigraphic vascular obstruction at recurrence of pulmonary embolism and after thrombolytic therapy: a case reportM A Rodger, G Jones, F Raymond, et al.Journal of Cell Science|October 11, 2018
The AAA ATPase Afg1 preserves mitochondrial fidelity and cellular health by maintaining mitochondrial matrix proteostasisEdward M Germany, Nataliya Zahayko, Mason L Huebsch, et al.Bone Marrow Transplantation|January 22, 2013
Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulationD Sheppard, J Tay, A Bryant, et al.Experimental Hematology|March 1, 1993
Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantationM Crump, F Couture, M Kovacs, et al.Pageof 2